MFSD7 | Major facilitator superfamily domain containing 7 | Predicted membrane proteins
| | | | | Mixed |
MYADM | Myeloid-associated differentiation marker | Predicted membrane proteins Transporters
| | | | | Expressed in all |
MYADML2 | Myeloid-associated differentiation marker-like 2 | Predicted membrane proteins
| | | | | Tissue enriched |
NIPA2 | Non imprinted in Prader-Willi/Angelman syndrome 2 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
NIPAL4 | NIPA-like domain containing 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
NOX5 | NADPH oxidase, EF-hand calcium binding domain 5 | Predicted membrane proteins Transporters
| | | | | Group enriched |
OR1D5 | Olfactory receptor, family 1, subfamily D, member 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR1S1 | Olfactory receptor, family 1, subfamily S, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR2M2 | Olfactory receptor, family 2, subfamily M, member 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR2T1 | Olfactory receptor, family 2, subfamily T, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR4C5 | Olfactory receptor, family 4, subfamily C, member 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR51G1 | Olfactory receptor, family 51, subfamily G, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR51J1 | Olfactory receptor, family 51, subfamily J, member 1 (gene/pseudogene) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR51Q1 | Olfactory receptor, family 51, subfamily Q, member 1 (gene/pseudogene) | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR52B6 | Olfactory receptor, family 52, subfamily B, member 6 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR52L1 | Olfactory receptor, family 52, subfamily L, member 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR7G2 | Olfactory receptor, family 7, subfamily G, member 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
OR8K3 | Olfactory receptor, family 8, subfamily K, member 3 | G-protein coupled receptors Predicted membrane proteins
| | | | | Not detected |
PAQR5 | Progestin and adipoQ receptor family member V | Predicted membrane proteins
| | | | | Tissue enhanced |
PAQR6 | Progestin and adipoQ receptor family member VI | Predicted membrane proteins
| | | | | Tissue enriched |
PAQR7 | Progestin and adipoQ receptor family member VII | Predicted membrane proteins
| | | | | Mixed |
PAQR8 | Progestin and adipoQ receptor family member VIII | Predicted membrane proteins
| | | | | Mixed |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted membrane proteins
| | | | | Tissue enhanced |
PHTF1 | Putative homeodomain transcription factor 1 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PHTF2 | Putative homeodomain transcription factor 2 | Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
PIEZO2 | Piezo-type mechanosensitive ion channel component 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
PIGQ | Phosphatidylinositol glycan anchor biosynthesis, class Q | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
PIGV | Phosphatidylinositol glycan anchor biosynthesis, class V | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
POMT1 | Protein-O-mannosyltransferase 1 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
PORCN | Porcupine homolog (Drosophila) | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
PSEN1 | Presenilin 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
PSEN2 | Presenilin 2 (Alzheimer disease 4) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
RHBG | Rh family, B glycoprotein (gene/pseudogene) | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
RHCE | Rh blood group, CcEe antigens | Blood group antigen proteins CD markers Predicted membrane proteins Transporters
| | | | | Tissue enriched |
RXFP2 | Relaxin/insulin-like family peptide receptor 2 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Not detected |
RYR1 | Ryanodine receptor 1 (skeletal) | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SCAP | SREBF chaperone | Predicted membrane proteins
| | | | | Expressed in all |
SEC61A2 | Sec61 alpha 2 subunit (S. cerevisiae) | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC10A1 | Solute carrier family 10 (sodium/bile acid cotransporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC10A2 | Solute carrier family 10 (sodium/bile acid cotransporter), member 2 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC10A3 | Solute carrier family 10, member 3 | Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Expressed in all |
SLC10A4 | Solute carrier family 10, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC10A6 | Solute carrier family 10 (sodium/bile acid cotransporter), member 6 | Predicted membrane proteins
| | | | | Group enriched |
SLC14A1 | Solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A3 | Solute carrier family 16 (monocarboxylate transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
SLC17A2 | Solute carrier family 17, member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC1A3 | Solute carrier family 1 (glial high affinity glutamate transporter), member 3 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A11 | Solute carrier family 22 (organic anion/urate transporter), member 11 | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SLC22A12 | Solute carrier family 22 (organic anion/urate transporter), member 12 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC22A18 | Solute carrier family 22, member 18 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |